Tagrisso (osimertinib) - AstraZeneca
paclitaxel - Generic mfg.
gemcitabine - Generic mfg.
navitoclax (ABT 263) - AbbVie
docetaxel - Generic mfg.
Gilotrif (afatinib) - Boehringer Ingelheim
Identification of anoikis-related and cell matrix adhesion genes in the progression of colon adenocarcinoma using bioinformatics analysis. (PubMed, Comput Methods Biomech Biomed Engin) - Sep 24, 2026 - "High-risk patients were more sensitive to afatinib, osimertinib, and navitoclax; low-risk patients to paclitaxel, docetaxel, and gemcitabine. These genes may serve as prognostic biomarkers and guide tailored COAD therapy." 
Journal • Colon Adenocarcinoma • Colon Cancer • Colorectal Adenocarcinoma • Colorectal Cancer • Oncology • BST2 • HOTAIR
http://www.ncbi.nlm.nih.gov/pubmed/42775455
 
Jianjiang Jin; Li Zhou; Ting Zheng; Xingxing Li
 
Sep 24, 2026
 
Prev Next